New Midlands account manager appointed at Burkert New Midlands account manager appointed at Burkert Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Dr Mathew Minardi joins Sterling Pharma Solutions Dr Mathew Minardi joins Sterling Pharma Solutions Stuart Ashman joins SkinBioTherapeutics Stuart Ashman joins SkinBioTherapeutics Pierre Fabre names new pharma CEO Pierre Fabre names new pharma CEO Jean-Luc Lowinski, a former Sanofi executive, spearheads Pierre Fabre Pharmaceuticals Biopharma names new Group Sales Director Biopharma names new Group Sales Director Dr Roberto Castangia has taken the baton from Peter Williams who has chosen to retire, effective June 2019 GEA makes key appointments GEA makes key appointments Parker Bioscience Filtrations appoints new general manager of UK site Parker Bioscience Filtrations appoints new general manager of UK site Kris Holmes will take up the role and help drive growth in the EMEA region Dr Frederick Hausheer joins WuXi AppTec to lead cancer drug development Dr Frederick Hausheer joins WuXi AppTec to lead cancer drug development Chinese pharma giant has appointed Dr Hausheer as Chief Medical Officer Oxford BioDynamics appoints new President for US subsidiary Oxford BioDynamics appoints new President for US subsidiary Glen Ferguson has been made Senior VP of US at the parent company, but has also been appointed as the President of the new US subsidiary Mologic expands US and UK operations Mologic expands US and UK operations The UK-based company that develops lateral flow and rapid diagnostic technologies has made multiple appointments in order to bolster US presence New Managing Director Sales at Uhlmann New Managing Director Sales at Uhlmann Michael Mrachacz succeeds Siegfried Drost PCI Pharma Services appoints new SVP and CFO PCI Pharma Services appoints new SVP and CFO Dr Norman Sharpless has big shoes to fill as new Acting FDA Commissioner Dr Norman Sharpless has big shoes to fill as new Acting FDA Commissioner The former National Cancer Institute Director, Dr Norman “Ned” Sharpless, has personal commercial experience in the drug industry and mirrors his predecessor’s views on... Former Eli Lilly executive joins iOnctura Former Eli Lilly executive joins iOnctura Michael Lahn has joined the late-stage preclinical immuno-oncology company as the new Chief Medical Officer PCI Pharma Services announces new Director of Clinical Supply Chain PCI Pharma Services announces new Director of Clinical Supply Chain